Roth Capital


AcelRx Pharmaceuticals Inc (ACRX) Could Face Opioid Heat from FDA with Zalviso, Worries Roth Capital

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) investors are quaking today in the upshot of earnings not so far off the mark from second quarter expectations. …

Roth Capital Sets High Expectations on Shopify Inc (US) (SHOP) and Glu Mobile Inc. (GLUU) Ahead of Earnings

As Shopify Inc (US) (NYSE:SHOP) and Glu Mobile Inc. (NASDAQ:GLUU) ready to release second quarter earnings next Tuesday, analyst Darren Aftahi of Roth Capital dives …

Roth Capital Sings the Praises of First Solar, Inc. (FSLR) Following Strong Q2 Beat

First Solar, Inc. (NASDAQ:FSLR) shares jumped nearly 11% in pre-market Friday, after the solar panel maker posted better than expected second-quarter results on strong …

Glu Mobile Inc. (GLUU) Partners with WWE for the Making of New Wrestling Game: Another Tap Sports Baseball Phenomenon Ahead?

Just two days ago, Glu Mobile Inc. (NASDAQ:GLUU) announced it had entered into a multi-year partnership with global entertainment leader WWE to develop …

Kite Pharma Inc (KITE) Takes Compelling Step Forward Toward Securing Broad Label in Non-Hodgkin Lymphoma

Yesterday, Kite Pharma Inc (NASDAQ:KITE) impressed at the 2017 American Association of Cancer Research annual meeting, presenting an encouraging full six- month data …

Top Analyst Slashes Price Target for Uni-Pixel Inc (UNXL)

Roth Capital’s top analyst Brian Alger is out with a new research note on shares of Uni-Pixel Inc (NASDAQ:UNXL), after the touch-screen technology maker reported in-line fourth quarter-results, offset …

Roth Capital Boosts Price Target for Kite Pharma Inc (KITE) on the Back of Positive Six Month ZUMA-1 Data

Kite Pharma Inc (NASDAQ:KITE) shares are on the run, after the drug maker announced the much-awaited top line results from its Phase 2 ZUMA-1 …